Deltamethrin, a pyrethroid insecticide, could be a promising candidate as an anticancer agent
Anoop Kumar1, Dinakar Sasmal1, Neelima Sharma1
1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India.
Medical Hypotheses
|May 19, 2015
Summary
Deltamethrin, a pyrethroid insecticide, shows potential as an anticancer agent by inducing apoptosis. Further research is needed to evaluate its therapeutic and toxic effects for potential clinical trials.
Area of Science:
- Oncology
- Toxicology
- Insecticide Research
Background:
- Cancer remains a leading cause of death with increasing incidence.
- Current anticancer agents have limitations in effectively treating cancer.
- Exploring novel mechanisms of existing molecules can lead to improved anticancer therapies.
Purpose of the Study:
- To investigate the potential of deltamethrin as an anticancer agent.
- To explore the apoptogenic signaling pathways induced by deltamethrin.
- To assess the therapeutic and toxic effects of deltamethrin for potential clinical application.
Main Methods:
- Review of in vitro and in vivo studies on deltamethrin's anticancer properties.
- Analysis of deltamethrin's role in inducing apoptogenic signaling pathways.
- Evaluation of deltamethrin's therapeutic and toxic effects.
Main Results:
- Deltamethrin, at low concentrations, demonstrated potential in inducing apoptogenic signaling pathways.
- These pathways are crucial for anticancer action.
- Deltamethrin exhibits potential as a novel anticancer agent.
Conclusions:
- Deltamethrin shows promise as a potential anticancer agent due to its ability to induce apoptosis.
- Further in vitro and in vivo evaluations are necessary to determine its clinical viability.
- Clinical trials require comprehensive assessment of both therapeutic benefits and toxic effects.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:10Drugs that Destabilize Microtubules
4.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
01:15Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
02:18Cancer
56.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.0K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K